✦ LIBER ✦

Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome

✍ Scribed by Gruhn, B; Hongeng, S; Yi, H; Hancock, M L; Rubnitz, J E; Neale, G A M; Kitchingman, G R

Book ID: 110053813
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 102 KB
Volume: 12
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2400985

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of minimal residua

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse

✍ Coustan-Smith, E; Gajjar, A; Hijiya, N; Razzouk, B I; Ribeiro, R C; Rivera, G K; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

Clinical significance of minimal residua

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse

✍ von Stackelberg, A; Seeger, K; Henze, G; Eckert, C 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 62 KB

Copy number alterations in childhood acu

Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease

✍ Doris Steinemann; Gunnar Cario; Martin Stanulla; Leonid Karawajew; Marcel Tausch 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

## Abstract In vivo response to initial therapy, as assessed by determination of minimal residual disease (MRD) after 5 and 12 weeks of treatment, has evolved as a strong prognostic factor in children with acute lymphoblastic leukemia (ALL) treated according to the BFM regime. Individual treatment

Potential of LightCycler technology for

Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia

✍ Eckert, C; Landt, O; Taube, T; Seeger, K; Beyermann, B; Proba, J; Henze, G 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 250 KB

Kinetics of minimal residual disease dur

Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia

✍ C. Scholten; M. Födinger; M. Mitterbauer; K. Laczika; G. Mitterbauer; O. A. Haas 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 615 KB

In vitro cellular drug sensitivity at di

In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia

✍ Gudmar Lönnerholm; Ingrid Thörn; Christer Sundström; Britt-Marie Frost; Jonas Ab 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 370 KB